Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection

Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection

Background & Aims: Novel finite therapies for chronic hepatitis B (CHB) are needed, since lifelong treatment is usually required with current available oral antivirals. This phase II study (NCT03615066) evaluated the safety, pharmacodynamics, and antiviral activity of selgantolimod (a Toll-l...

Full description

Bibliographic Details
Main Authors:	Harry L. Janssen, Young-Suk Lim, Hyung Joon Kim, Leonard Sowah, Cheng-Hao Tseng, Carla S. Coffin, Magdy Elkhashab, Sang Hoon Ahn, Anh-Hoa Nguyen, Diana Chen, Jeffrey J. Wallin, Simon P. Fletcher, Circe McDonald, Jenny C. Yang, Anuj Gaggar, Diana M. Brainard, Scott Fung, Yoon Jun Kim, Jia-Horng Kao, Wan-Long Chuang, Anna E. Brooks, P. Rod Dunbar
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	JHEP Reports
Subjects:	Hepatitis B virus oral antiviral small molecule immunotherapy HBV cure toll-like receptor
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555923003063

Similar Items

Oral Selective TLR8 Agonist Selgantolimod Induces Multiple Immune Cell Responses in Humans
by: Natarajan Ayithan, et al.
Published: (2021-11-01)

Immediate postpartum cessation of tenofovir did not increase risk of virological or clinical relapse in highly viremic pregnant mothers with chronic hepatitis B infection
by: Yu Chen, et al.
Published: (2024-05-01)

Association of toll-like receptors single nucleotide polymorphisms with HBV and HCV infection: research status
by: Yaxin Xu, et al.
Published: (2022-04-01)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
by: Abhishek Aggarwal, et al.
Published: (2023-04-01)

Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review
by: Saeed Soleiman-Meigooni, et al.
Published: (2024-03-01)

Struktur tarif tol bagi sistem leburaya tertutup [compact disc] /
by: 235090 Fahd Naim Faudzi Naim
Published: (2004)

Struktur tarif tol bagi sistem leburaya tertutup /
by: 235090 Fahd Naim Faudzi Naim
Published: (2004)

Hepatitis B vaccination in leprosy patients
by: Heitor Rosa, et al.
Published: (1994-09-01)

Diversity of Hepatitis B genotypes in Nepal and updated Phylogenetic Tree: a Pilot Survey in 2012
by: Damodar Paudel, et al.
Published: (2014-12-01)

Hepatitis B Core Antigen Impairs the Polarization While Promoting the Production of Inflammatory Cytokines of M2 Macrophages via the TLR2 Pathway
by: Hongyu Yi, et al.
Published: (2020-03-01)

Persistent Hepatitis B Viraemia with Polymerase Mutations among HIV/HBV Co-Infected Patients on HBV-Active ART in KwaZulu-Natal, South Africa
by: Nokukhanya Msomi, et al.
Published: (2022-04-01)

The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review
by: Shang‐Chin Huang, et al.
Published: (2024-01-01)

Persepsi pengguna lebuh raya kelas satu terhadap bayaran tol serta kemudahan-kemudahan yang disediakan oleh Plus Berhad : kajian kes di Plaza Tol Senai /
by: Siti 'Azami Mujahidah Mohamed
Published: (2000)

A toll plaza simulation model and level-of-service criteria /
by: 374758 Wanisubut, Suwat
Published: (1989)

Tool financing and private sector involvement in road infrastructure development/
by: Organisation for Economic Co-Operation and Development. Scientific Expert Group
Published: (1987)

Toll roads and bridges
Published: (1981)

The Culprit Behind HBV-Infected Hepatocytes: NTCP
by: Li S, et al.
Published: (2024-10-01)

Na<sup>+</sup>-Taurocholate Co-Transporting Polypeptide (NTCP) in Livers, Function, Expression Regulation, and Potential in Hepatitis B Treatment
by: Xiaoyu Zhao, et al.
Published: (2021-11-01)

HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
by: Lorenzo Piermatteo, et al.
Published: (2021-09-01)

Editorial: HBV and lymphoma
by: Giuseppe Gentile, et al.
Published: (2023-07-01)

A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod
by: Sharon A. Riddler, et al.
Published: (2024-09-01)

The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus
by: Ankoor Patel, et al.
Published: (2024-01-01)

Incidental hepatitis B virus in Sudanese patients and relative risk factors: Why more screening is needed in primary care?
by: Haifaa A M. Hassan, et al.
Published: (2022-01-01)

Electronic fee collection in economies in transition : introductory report
by: Permanent International Association of Road Congresses. Technical Committee on Surface Characteristics, et al.
Published: (1999)

Kajian sistem tol : muatan jalan /
by: 435970 Kamarudin Mustapha
Published: (1991)

Private sector involvement and toll road financing in the provision of highways/
by: National Research Council (United States). Transportation Research Board
Published: (1987)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
by: Sara Battistella, et al.
Published: (2023-04-01)

Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in Blumenau, State of Santa Catarina, Brazil, 2007-2008 Níveis de anti-HBs entre crianças e adolescentes com o esquema completo de imunização contra o vírus da hepatite B. Um estudo transversal em Blumenau, Estado de Santa Catarina, 2007-2008
by: Andréa do Livramento, et al.
Published: (2011-08-01)

Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis
by: Keith C.K. Lau, et al.
Published: (2020-09-01)

The pattern change of hepatitis B virus genetic diversity in Northwestern Tanzania
by: Mathias Mlewa, et al.
Published: (2025-03-01)

Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy
by: Romina Salpini, et al.
Published: (2025-01-01)

MicroRNA levels in patients with chronic hepatitis B virus and HIV coinfection in a high-prevalence setting; KwaZulu-Natal, South Africa
by: Lulama Mthethwa, et al.
Published: (2024-08-01)

The N-Terminus Makes the Difference: Impact of Genotype-Specific Disparities in the N-Terminal Part of The Hepatitis B Virus Large Surface Protein on Morphogenesis of Viral and Subviral Particles
by: Bingfu Jiang, et al.
Published: (2020-08-01)

Hepatitis B Virus Exploits ERGIC-53 in Conjunction with COPII to Exit Cells
by: Lisa Zeyen, et al.
Published: (2020-08-01)

Hepatitis B Virus Research in South Africa
by: Mohube B. Maepa, et al.
Published: (2022-08-01)

HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review
by: Giuseppe Gentile, et al.
Published: (2019-11-01)

OCCULT HEPATITIS B VIRUS INFECTION AND ASSOCIATED GENOTYPES AMONG HBSAG-NEGATIVE SUBJECTS IN BURKINA FASO
by: Birama DIARRA, et al.
Published: (2018-01-01)

Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy
by: Yasuhito Tanaka, et al.
Published: (2024-05-01)

The association of lncRNA SNPs and SNPs‐environment interactions based on GWAS with HBV‐related HCC risk and progression
by: Qing Liu, et al.
Published: (2021-02-01)

Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report
by: Gian Paolo Caviglia, et al.
Published: (2021-11-01)